|
US5338723A
(en)
*
|
1989-10-13 |
1994-08-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
JPH06500547A
(ja)
*
|
1990-09-14 |
1994-01-20 |
ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
ピリジルメチルスルフィニル―１ｈ―ベンゾイミダゾール誘導体のヘリコバクターにより起こされる病気の治療のための使用
|
|
TW209174B
(no)
*
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
|
TW276996B
(no)
*
|
1992-04-24 |
1996-06-01 |
Astra Ab |
|
|
US5504082A
(en)
*
|
1992-06-01 |
1996-04-02 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Pyridine compound and pharmaceutical compostions
|
|
CA2138787A1
(en)
*
|
1992-07-08 |
1994-01-20 |
Clifton Augustus Baile |
Alleviating stomach ulcers in swine
|
|
EP0652751B1
(en)
*
|
1992-07-28 |
1996-10-23 |
Astra Aktiebolag |
Injection and injection kit containing omeprazole and its analogs
|
|
EP0585722B1
(en)
*
|
1992-08-21 |
1996-05-15 |
Eisai Co., Ltd. |
Benzimidazole derivatives as antimicrobal agent against Campylobacter pylon
|
|
AU5699594A
(en)
*
|
1992-12-10 |
1994-07-04 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Use of alkylthiopyridines for controlling helicobacter bacteria
|
|
JPH06298611A
(ja)
*
|
1993-04-16 |
1994-10-25 |
Nippon Chemiphar Co Ltd |
抗菌剤
|
|
PL178477B1
(pl)
*
|
1993-06-29 |
2000-05-31 |
Byk Gulden Lomberg Chem Fab |
Nowe związki, pochodne arylotioalkilotiopirydyny, oraz sposób ich wytwarzania i lek zawierający te związki
|
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
|
DE69918799D1
(de)
|
1998-01-14 |
2004-08-26 |
Uab Res Foundation Birmingham |
Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
|
|
US6861448B2
(en)
*
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
|
FI104384B
(fi)
|
1998-06-05 |
2000-01-14 |
Valmet Corp |
Laitteisto ja menetelmä viiraveden ja tuoremassan sekoittamiseksi viirakaivon jälkeisessä kanavassa
|
|
CA2419067C
(en)
*
|
2000-08-18 |
2008-12-23 |
Takeda Chemical Industries, Ltd. |
Injectable composition comprising benzimidazole compound and strong alkali
|
|
EP1428825A4
(en)
*
|
2001-09-18 |
2005-03-23 |
Zeria Pharm Co Ltd |
benzimidazole derivatives
|
|
US9358214B2
(en)
*
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
|
MXPA04007169A
(es)
*
|
2002-01-25 |
2004-10-29 |
Santarus Inc |
Suministro transmucosal de inhibidores de bomba de protones.
|
|
US8367111B2
(en)
*
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
|
WO2004073654A2
(en)
*
|
2003-02-20 |
2004-09-02 |
Santarus, Inc. |
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
|
|
EP1648417A4
(en)
*
|
2003-07-18 |
2010-01-20 |
Santarus Inc |
PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF GASTROINTESTINAL ACIDITY RELATED DISORDERS
|
|
EP1648416A4
(en)
*
|
2003-07-18 |
2012-03-28 |
Santarus Inc |
PHARMACEUTICAL FORMULATIONS FOR INHIBITING THE ACIDIC ACIDIFICATION AND MANUFACTURING AND USE METHOD
|
|
US8993599B2
(en)
*
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
|
WO2005076987A2
(en)
*
|
2004-02-10 |
2005-08-25 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
|
|
JP2007532677A
(ja)
*
|
2004-04-16 |
2007-11-15 |
サンタラス インコーポレイティッド |
プロトンポンプ阻害剤、緩衝剤、および運動促進薬の組み合わせ
|
|
US8815916B2
(en)
*
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US8906940B2
(en)
*
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
|
US8747895B2
(en)
*
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
|
WO2006047493A2
(en)
*
|
2004-10-21 |
2006-05-04 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
|
EP1934201A1
(en)
*
|
2005-10-06 |
2008-06-25 |
Auspex Pharmaceuticals Inc. |
Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
|
|
KR101348643B1
(ko)
*
|
2006-03-10 |
2014-01-08 |
링크 제노믹스 가부시키가이샤 |
항 헬리코박터피로리 작용을 가지는 신규 피리딘 유도체
|
|
EP2026768B1
(en)
*
|
2006-06-01 |
2018-02-28 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
|
EP2023721A2
(en)
*
|
2006-06-05 |
2009-02-18 |
Auspex Pharmaceuticals Inc. |
Preparation and utility of substituted erythromycin analogs
|
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
|
GB2459393B
(en)
|
2006-10-05 |
2010-09-08 |
Santarus Inc |
Novel capsule formulation for the proton pump inhibitor omeprazole
|
|
US20080103169A1
(en)
|
2006-10-27 |
2008-05-01 |
The Curators Of The University Of Missouri |
Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
|
|
RU2484089C1
(ru)
*
|
2009-04-09 |
2013-06-10 |
Ариджен Фармасьютикалз, Инк. |
Тиопроизводное пиридина и фармацевтическая композиция, которая его содержит и имеет способность действовать против helicobacter pylori
|
|
CN102958515A
(zh)
|
2009-12-02 |
2013-03-06 |
阿普塔利斯制药有限公司 |
非索非那定微胶囊及含有非索非那定微胶囊的组合物
|
|
AR079862A1
(es)
*
|
2010-01-08 |
2012-02-22 |
Eurand Inc |
Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion
|
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|